Modified Citrus Pectin
Resource Center
/ Recent Posts /
A 30-Year Investigation Into Culprit Biomarker Galectin-3: From Survival to Sepsis—and Beyond
For more than 30 years, Isaac Eliaz, MD, MS, LAc, has investigated Galectin-3 and its role in inflammation, fibrosis, cancer, kidney injury, sepsis, and emerging ...
Demystifying Endotoxins: Identifying and Quenching the Fire Within
Join functional medicine pioneer Dr. Tom O’Bryan, DC, CCN, DACBN, CIFM, as he shares breakthrough research, clinical strategies, and functional medicine frameworks to understand, diagnose, ...
A New Understanding of Endotoxin Trafficking and Chronic Inflammation
Arguably, the most prominent ‘sleeper’ disease that contributes to 1 in every 2 to 3 hospital deaths is sepsis.1 Fueled by lipopolysaccharide (LPS)2— referred to ...
Galectin-3 and MCP: Brain Health, Cognitive Function and Beyond
Galectin-3 is emerging as a key biomarker and driver of inflammation, fibrosis and chronic disease. This review examines the clinical relevance of galectin-3 and the ...
Preventing Cancer Progression and Metastasis: The Role of Modified Citrus Pectin in Targeting Galectin-3
MCP has demonstrated significant anticancer activity in vitro, in animal studies, and in clinical studies. Beyond its anticancer properties, MCP is shown to improve metal ...
Blocking Galectin-3 for Health and Longevity
In this video, Josh Helman, MD discusses the pathogenic mechanisms of the pro-inflammatory immune protein galectin-3 and its role in neurodegenerative diseases, biofilm formation, autoimmunity ...
Blocking Galectin-3 with Modified Citrus Pectin Supports Cognition and May Help Prevent Alzheimer’s
Cognitive impairment and the development of Alzheimer’s disease are recognized risk factors in type 2 diabetes mellitus. Research continues to link metabolic dysregulation and specifically, insulin resistance, with ...
Blocking Galectin-3: A Powerful Strategy for Neurodegeneration and Chronic Disease
Over the last decade or so, research interest in the pro-inflammatory and pro-fibrotic immune protein galectin-3 (Gal-3) has skyrocketed. Today, thousands of published scientific papers—including ...
